Chicago Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Chicago Capital Management's ICPT Position: Q4 2023 in Review
Chicago Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 185,781 shares — an estimated $4.61M sold.
Chicago Capital Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $4.61M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Chicago Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Chicago Capital Management sold 185,781 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $4.61M.
- Chicago Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
- Chicago Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $4.61M in Q3 2023.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Chicago Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.